Lv5
820 积分 2025-09-14 加入
Therapy for Stage IV Non–Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, 2026.3.0
7小时前
已完结
Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group
7小时前
已完结
Rare SMARCA4-deficient thoracic tumor: Insights into molecular characterization and optimal therapeutics methods
7小时前
已完结
Immunotherapy-based combination remodels the immunosuppressive microenvironment and enhances efficacy in advanced SMARCA4-deficient non-small cell lung cancer
7小时前
已完结
Efficacy of antiangiogenic therapy in patients with advanced SMARCA4-deficient thoracic tumor
7小时前
已完结
Non–Small Cell Lung Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In Oncology
8小时前
已完结
SMARCA4: Promises and challenges in the treatment of cancers
1个月前
已完结
Hyperprogressive Disease After Immunotherapy: A Case Report of Pulmonary Enteric Adenocarcinoma
2个月前
已关闭
Imaging performance of thoracic SMARCA4-deficient undifferentiated tumor: a case report and literature review
2个月前
已完结
Acquired SMARCA4 alterations: An uncommon contributor to cancer progression in lung adenocarcinomas
2个月前
已完结
皖公网安备34019202002308
